Please use this identifier to cite or link to this item: http://10.9.150.37:8080/dspace//handle/atmiyauni/2146
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSavant, Mahesh M.-
dc.date.accessioned2025-01-01T06:37:58Z-
dc.date.available2025-01-01T06:37:58Z-
dc.date.issued2023-
dc.identifier.issn1735-2428-
dc.identifier.urihttp://10.9.150.37:8080/dspace//handle/atmiyauni/2146-
dc.description.abstractNovel hybrid molecules of thiazolopyrimidine 4a–j have been prepared starting fromvarious thiazoles 3a–j . The reaction of thiazoles 3a–j with thiourea yielded hybridmolecules 4a–j in an excellent yield. These molecules were screened for their anticanceractivities against human breast carcinoma cell line (MCF-7), human lungadenocarcinoma cell line (A549) and human cervical cancer cell line (HeLa) using MTTassay. Among all molecules, compounds 4g and 4f exhibited potent cytotoxic activity.Compound 4g with IC value of 3.1 ± 0.4 μM and IC value of 9.8 ± 0.4 μM against A549and HeLa cell line, respectively. Compound 4f with IC value of 6.8 ± 0.7 μM against MCF-7 molecular docking study of all synthesized molecules 4a–j was performed onen_US
dc.language.isoenen_US
dc.publisherJournal of the Iranian Chemical Societyen_US
dc.titleSynthesis of thiazolo[3,2-a]pyrimidine molecules, in vitro cytotoxic evaluation and molecular docking studiesen_US
dc.typeArticleen_US
Appears in Collections:01. Journal Articles

Files in This Item:
File Description SizeFormat 
Synthesis of thiazolo[3,2-a]pyrimidine molecules, in vitro cytotoxic evaluation and molecular docking studies _ Journal of the Iranian Chemical Society.pdf842.8 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.